AI Governance

A new white-label infrastructure from PsyMetrics allows independent HR advisors to rebrand assessment tech, aiming to end "client leakage" to large vendors.

Big Pharma is pouring over $1 billion into AI to design complex drugs, trading lab guesswork for algorithms. It's a high-stakes play to fix a broken R&D model.

Sharon AI and VAST Data are building a digital fortress. Their 600-petabyte deal isn't just about storage; it's a strategic move to forge a sovereign AI future for Australia.

Boy George's 'Karma Chameleon' gets an AI-assisted update. A new model from Syntiant and Artist Included promises to honor legacies, not erase them.

A new partnership between Klick Labs and Mayo Clinic aims to detect disease using your voice. But what does this mean for the future of our health systems?

A new cybersecurity mandate is cleaving the defense industry in two. Vistra's recent certification highlights a growing chasm between the compliant few and the unprepared many.

A new partnership between AI consultancy Toboggan Labs and research giant Mila aims to solve a critical problem: turning cutting-edge AI into real-world medical tools.

Lexeo Therapeutics finalizes a pivotal trial for its Friedreich ataxia gene therapy, leveraging a novel trial design and accelerated FDA pathway.

A new study reveals 99% of European firms feel pressure to scale AI in customer experience, but only 38% have governance, risking trust and compliance.

French insurer APRIL now offers real insurance quotes via ChatGPT. It’s not just a tech demo; it’s a glimpse into the future of the 2026 consumer experience.

Manulife's entry into a key regulatory AI program signals a sector-wide shift. How Hong Kong is using collaboration to build its future as a FinTech hub.

Shifters' new AI-native ecosystem moves beyond remote control, enabling supervised robotic teams to enter dangerous zones first. What does this mean for safety?

A hidden multi-billion dollar industry promises access to justice but is increasingly blamed for "nuclear verdicts" that raise costs for everyone. Is it a leveler or a liability?

New research reveals AI engines are inventing 1 in 5 celebrity deals and warping financial reputations around single events, signaling a new corporate battleground.

EXL's new Gold Tier status with Databricks isn't just a partnership upgrade; it's a strategic move to solve AI's biggest business problem: data governance.

Jazz Pharma's lung cancer drug Zepzelca fails a key trial, raising regulatory questions. Yet its strength in another setting reveals a complex drug development system.

With Bill C-34, Canada wants to make social media and AI safer for children. But can it balance protection with privacy and digital freedom?

A new partnership aims to audit and verify tradable AI 'Skills.' We dissect how applying blockchain security principles could unlock a multi-billion dollar AI Agent economy.

While firms spend billions on tech, a new book argues the biggest data breaches stem from leadership gaps and process failures. Is your boardroom the real front line?

Ottawa's new Safe Social Media Act imposes strict duties on tech giants to protect children, but raises critical questions about privacy and digital freedom.